#cardiovascular

-     Since its launch 21 years ago Synexus has grown from a small clinic adjoining founder Dr Smith's ...

- Transaction Designed to Enhance Shareholder Value By Unlocking Value of the Epigenetics Platform- TSX Exchange ...

-     Virobay, Inc. and LEO Pharma A/S today announced that their collaboration on the development ...

-On World Cancer Day, UICC and International Agency for Research on Cancer (IARC) reveal real-life impact of achieving ...

-- Experts recommend comprehensive approach to combat global health issue -     A new Economist ...

- PneumRx, Inc., a leader in interventional pulmonology, announced today that University Medical Center Groningen has ...

- Telome Health, Inc. (THI), developer of the TeloTest(TM) diagnostic test that measures average telomere length, ...

-     FALCON (Fulvestrant and AnastrozoLe COmpared in hormonal therapy Naïve advanced breast ...

-Survival of patients treated with SIR-Spheres more than double that of patients who received best supportive care, ...

- Takeda Global Research and Development (Asia) Pte Ltd (TGRD Asia), a wholly owned subsidiary of Takeda Pharmaceutical ...

People who take statins to reduce their risk of cardiovascular disease are less likely to be diagnosed with the most ...

- Resverlogix Corp. (TSX:RVX) today announced that it has completed enrollment in ASSURE, a Phase 2b clinical trial ...

-      * State-of-the-art facility in Yaroslavl demonstrates Takeda's long-term commitment to ...

Resverlogix Corp. (TSX: RVX) today announced that the BET protein inhibitor RVX-208 significantly increased HDL-C ...

- The Power Over Pressure steering committee today announced the launch of the world's first online resource created to ...